A clinical trial report, published in the Journal of Alternative and Complementary Medicine, evaluated the effects of KSM-66 Ashwagandha on thyroid hormone levels. The double blind, randomized, placebo-controlled trial had a sample size of 50 subjects. An eight-week supplementation of KSM-66 Ashwagandha significantly improved serum TSH, serum T4 and serum T3 levels, achieving change toward normalization of 19 percent, 45 percent and 21 percent respectively. These findings are noteworthy because they indicate that KSM-66 Ashwagandha can normalize thyroid hormone levels in hypothyroid individuals and also maintain normal thyroid function in healthy people.
Kartikeya Baldwa, director of Ixoreal Biomed, the marketer of KSM-66, said: "Ashwagandha has been used traditionally as an adaptogen to rejuvenate health, maintain homeostasis, sustain normal thyroid function and maintain hormonal balance in human body. However, very few modern published papers have reported ashwagandha’s beneficial effects on thyroid function. This is the first clinical study that supports the traditional claim of ashwagandha as a thyroid modulator.”
Baldwa added: "From the scientific literature, we know that ashwagandha root is a calming agent and promotes balance in the body to increase or decrease key hormone levels to bring them to appropriate levels. The present publication bolsters the clinical usage of KSM-66 Ashwagandha for maintaining normal thyroid function. KSM-66 is one of the few ingredients shown to be clinically effective for this application.” Ixoreal is the industry leader in clinical trials and basic research investigating the effectiveness of ashwagandha, with 24 studies: 10 published studies, six additional studies completed and in peer review and eight ongoing studies.
Source: KSM-66 Ashwagandha